Skip to main content area

Roadshow

Radiate NEXT

Committed to the development of innovative crop production technology, CH Biotech’s  sustainable agrochemical product “Radiate NEXT” has been approved as an innovative product by the Ministry of Economic Affairs according to the “Act for the Development of Biotech and New Pharmaceutical Industry.” The product has also successfully obtained a product registration from the U.S. Environmental Protection Agency (U.S. EPA) after rigorous review. In yet another remarkable achievement, it has been honored with the “2023 Taiwan Bio Awards – Innovation of the Year;” on July 27, 2023, CH Biotech is awarding the honor from the Taiwan Bio Industry Organization (Taiwan BIO) during the BioAsia Taiwan.

In the last few years, extreme weather events have intensified. Particularly after June of this year, the global temperature is keeping high, and there are severe floods or extreme phenomena of high temperature and drought in various regions. Additionally, ongoing conflicts in major grain-producing regions like Ukraine have led to reduced food production, resulting in global food crisis. There is an urgent need for agricultural biotech solutions that can fight against adverse climate and increase crop yield.

 

The range of crops covered by CH Biotech’s product “Radiate NEXT” is quite extensive. Apart from staple food crops like soybean, wheat, and corn, which are cultivated with large area, it also applies to high-value economic crops, such as vegetables, fruit, coffee, and cotton. Furthermore, since the launch of “Radiate NEXT,” the product and the Company have continuously received numerous awards in Taiwan, including the “CTSP Innovative Product Award,” “National Industrial Innovation Award of the Ministry of Economic Affairs,” “TCSA –Growth through Innovation Award,” “Global Views ESG Sustainable Award – Outstanding Project,” and the upcoming “2023 Taiwan Bio Awards – Innovation of the Year.”

 

As a sustainable product capable of reducing carbon emissions in agriculture, “Radiate NEXT” possesses the ability to promote plant growth and enhance plants’ resilience to environmental stresses. Even in drought conditions, it can maintain adequate moisture levels. In addition, it stimulates various types of enzyme activity of single crops, improves metabolic reactions, and enhances fertilizer utilization efficiency. As a result, it can increase yields while reducing the usage of fertilizer. Through these effects, it contributes to lowering carbon emissions from arable land, thereby facilitating the goal of achieving net-zero carbon emissions in agriculture.

 

In 2022, “Radiate NEXT” was listed as a recommended carbon reduction product by distributors, aiming to encourage farmers to adopt measures to reduce fertilizer usage. By using “Radiate NEXT,” not only do farmers reduce the farmland carbon emissions from production and cultivation but also attain higher yield and profits, which further motivate them to use “Radiate NEXT” in their agricultural production.

 

Sources 

Video
CH Biotech R&D Co., LTD.
  • Established 2013
  • Company CH Biotech R&D Co., LTD.
  • Telephone +886-49-7009198
  • Address +886-49-2371717 No. 89, Wenxian Rd., Nantou City, Nantou County 540001, Taiwan

CH Biotech aims at the huge market of world agriculture for business opportunities and demands. We have created innovative core technologies and developed plant growth regulators and fertilizers of high effectiveness, precision, and low carbon which satisfy the production requirements of modern agriculture. For products developed by CH Biotech, we cooperate with distributors by adopting an innovative business model, “asymmetric vertical strategical alliance,” together with an exclusive sales model. Leveraging on the strategic layout of “Taiwan R&D, U.S. Manufacturing, and Worldwide Marketing,” we generate sales in the U.S., Canada, Australia, Brazil, Argentina, Uruguay, Chile, and other countries, and concurrently enjoy high profits arising from the new R&D models.

  • Establishment Date:11/29/2013
  • Listing Date on Emerging Stock Market:7/2/2015
  • Paid-in Capital:NT$844.2 million
  • Net Worth:NT$1.723 billion
  • Chairman:Wu, Zheng-Bang
  • Scope of Business:
    – Research, development, production, and sales of new agriculture chemicals and biotechnology
  • Locations:
    – Corporate headquarters and R&D center (Chung Hsing Park, Central Taiwan Science Park, Nantou, Taiwan)
    – Production Base (California, U.S.A.)
  • Number of Employees of the Group: 128 employees (1/31/2022)

Milestone

2022

  • Translated, printed, and distributed serial books “Recarbonizing Global Soils – A Technical Manual of Recommended Management Practices” published by the Food and Agriculture Organization of the United Nations.

2021

  • Formally established the Preparation Office of “National Chung Hsing University CH Research Institute.”
  • Recognized as a biotech and new drug company subject to the “Act for the Development of Biotech and New Pharmaceutical Industry” by the Ministry of Economic Affairs.
  • Received the “Continuing Advance Award” for entrepreneur innovation under the 2021 National Innovation Award – Agriculture and Food Biotechnology Group Enterprise Innovation Award, from the Biotech Medical Technology Policy Research Center.
  • Obtained a registration permit for a fermentation plant in Zhangbin Industrial Park.

2020

  • Performed capital increase from earnings; the paid-in capital was NT$844.2 million after the capital increase.
  • Received the “Annual Innovation Award” under the Taiwan BIO Awards from Taiwan Bio Industry Organization.
  • Received a Silver Award of the “Innovative Technology Award” under the “Taipei Biotech Awards” from the Taipei City Government.
  • Received the Outstanding Supplier Innovative Product Award from the Central Taiwan Science Park.

 

※All the following are required
field spacing
Back to top